The markets needed a breather after this week's chaotic nosedive, and they got a welcome respite today. The Dow Jones Industrial Average (DJINDICES: ^DJI ) hasn't done much today, hovering near breakeven this afternoon, but at least investors aren't getting hammered like they were earlier in the week. Blue-chip stocks are mixed evenly between risers and losers today, with only a few stocks moving significantly. It's unlikely that Wall Street has gotten over its irrational fear of the end of quantitative easing that quickly, however, so long-term investors should hold tight, as more volatility is likely to come. Let's get caught up on the top stories of the day.
P&G leads the way; B of A fades
Procter & Gamble (NYSE: PG ) is cruising full sail in today's calm market, leading the cadre of Dow risers higher. The consumer goods company's shares have jumped 1.6% as P&G continues to regroup under newly returned CEO A. G. Lafley. P&G has made the most of its brands lately, signing designer fragrance deals with the likes of Alexander McQueen and Stella McCartney. The company is also expanding geographically, looking to challenge rivals in emerging markets such as India. The firm recently invested heavily in its Indian unit, and while the business is small, Lafley also put much of his energy into growing the business during his previous tenure with P&G.
5 Best Undervalued Stocks To Invest In Right Now: Jarden Corp (JAH)
Jarden Corporation (Jarden), incorporated on December 11, 2001, is a global consumer products company. The Company operates in three segments through a range of brands, including: Outdoor Solutions: Abu Garcia, Aero, Berkley, Campingaz, Coleman, ExOfficio, Fenwick, Gulp!, K2, Marker, Marmot, Mitchell, Penn, Rawlings, Shakespeare, Stearns, Stren, Trilene, Volkl and Zoot; Consumer Solutions: Bionaire, Crock-Pot, FoodSaver, Health o meter, Holmes, Mr. Coffee, Oster, Patton, Rival, Seal-a-Meal, Sunbeam, VillaWare and White Mountain, and Branded Consumables: Ball, Bee, Bernardin, Bicycle, Billy Boy, Crawford, Diamond, Dicon, Fiona, First Alert, First Essentials, Hoyle, Kerr, Lehigh, Lillo, Loew-Cornell, Mapa, NUK, Pine Mountain, Quickie, Spontex and Tigex. On December 31, 2012, American Capital Ltd sold its portfolio company Lifoam Holdings, Inc. to the Company. In October 2013, Jarden Corporation completed its acquisition of Yankee Candle Investments LLC from a fund managed by Madison Dearborn Partners, LLC.
Outdoor Solutions
The Outdoor Solutions segment manufactures or sources, markets and distributes global consumer lifestyle products for outdoor and outdoor-related activities. For general outdoor activities, Coleman is a brand for lifestyle products, offering an array of products that include camping and outdoor equipment such as air beds, camping stoves, coolers, foldable furniture, gas grills, lanterns and flashlights, sleeping bags, tents and water recreation products, such as inflatable boats, kayaks and tow-behinds. The Outdoor Solutions segment is also a provider of fishing equipment under brand names, such as Abu Garcia, All Star, Berkley, Fenwick, Gulp!, JRC, Mitchell, Penn, Pflueger, Sebile, Sevenstrand, Shakespeare, Spiderwire, Stren, Trilene, Ugly Stik and Xtools. Team sports equipment for baseball, basketball, field hockey, football, lacrosse and softball products are sold under brand names, such as deBeer, Gait, Miken, Rawlings and Worth. Alpine and nordic skiing! , snowboarding, snowshoeing and in-line skating products are sold under brand names, such as Atlas, Full Tilt, K2, Line, Little Bear, Madshus, Marker, Morrow, Ride, Tubbs, Volkl and 5150 Snowboards.
Water sports equipment, personal flotation devices and all-terrain vehicle gear are sold under brand names, such as Helium, Hodgman, Mad Dog Gear, Sevylor, Sospenders and Stearns. The Company also sells technical and outdoor apparel and equipment under brand names, such as CAPP3L, Ex Officio, K2, Marker, Marmot, Planet Earth, Ride, Volkl and Zoot, and air beds under brand names, including Aero, Aerobed and Aero Sport. The Company has warehouse and distribution facilities in Canada, Europe, Latin America, the Pacific Rim and the United States. It also uses third party warehouses and logistical services. It manufactures its products at facilities in China, Europe, Latin America and North America, as well as through third-party sourcing, primarily in Asia.
Consumer Solutions
The Consumer Solutions segment manufactures or sources, markets, and distributes a line of household products, including kitchen appliances and home environment products. This segment maintains a portfolio of brands, including Bionaire, Crock-Pot, FoodSaver, Health o meter, Holmes, Mr. Coffee, Oster, Patton, Rival, Seal-a-Meal, Sunbeam and Villaware. The principal products in this segment include clippers and trimmers for professional use in the beauty and barber and animal categories; electric blankets, mattress pads and throws; household kitchen appliances, such as blenders, coffeemakers, irons, mixers, slow cookers, toasters, toaster ovens and vacuum packaging machines; home environmental products, such as air purifiers, fans, heaters and humidifiers; products for the hospitality industry, and scales for consumer use.
Branded Consumables
The Branded Consumables segment manufactures or sources, markets and distributes a line of branded consumer products, including arts and c! rafts pai! nt brushes, brooms, brushes, buckets, children�� card games, clothespins, collectible tins, condoms, cord, rope and twine, dusters, dust pans, feeding bottles, fencing, fire extinguishing products, firelogs and firestarters, home canning jars and accessories, kitchen matches, mops, other craft items, pacifiers, plastic cutlery, playing cards and accessories, rubber gloves and related cleaning products, safes, security cameras, security doors, smoke and carbon monoxide alarms, soothers, sponges, storage organizers and workshop accessories, teats, toothpicks, window guards and other accessories. This segment markets its products under the Aviator, Ball, Bee, Bernardin, Bicycle, Billy Boy, BRK, Crawford, Diamond, Dicon, Fiona, First Alert, First Essentials, Hoyle, Java-Log, KEM, Kerr, Lehigh, Lillo, Loew-Cornell, Mapa, NUK, Pine Mountain, Quickie Green Cleaning, Quickie Home-Pro, Quickie Microban, Quickie Original, Quickie Professional, Spontex, Tigex and Wellington brand names, among others.
The Company manufactures products, such as firelogs and firestarters, kitchen matches and metal closures for its home canning jars in its domestic facilities. It also manufactures playing cards and certain baby care products, home care products, healthcare products and home safety products at facilities worldwide, including facilities in Asia, Europe, Latin America, North America and South America.
Process Solutions
In addition to the three primary business segments, the Company�� Process Solutions segment manufactures, markets and distributes a variety of plastic products, including closures, contact lens packaging, medical disposables, plastic cutlery and rigid packaging. Its materials business produces specialty nylon polymers, conductive fibers and monofilament used in various products, including woven mats used by paper producers and weed trimmer cutting line, as well as fiberglass radio antennas for marine, citizen band and military applications. It is also a producer o! f niche p! roducts fabricated from solid zinc strip and is the supplier of copper-plated zinc penny blanks to the United States Mint and a supplier to the Royal Canadian Mint, as well as a supplier of brass, bronze and nickel-plated finishes on steel and zinc for coinage to other international markets. In addition, it manufactures a line of industrial zinc products marketed worldwide for use in the architectural, automotive, construction, electrical component and plumbing markets.
Advisors' Opinion:- [By WWW.GURUFOCUS.COM]
Consumer products manufacturer Jarden Corp. (JAH) announced strong, broad-based organic growth and closed on the acquisition of Yankee Candle.From Diamond Hill Capital (Trades, Portfolio)'s Select Fund Commentary for fourth quarter 2013.
Also check out: Diamond Hill Capital Undervalued Stocks Diamond Hill Capital Top Growth Companies Diamond Hill Capital High Yield stocks, and Stocks that Diamond Hill Capital keeps buying
Currently 5.00/512345Rating: 5.0/5 (1 vote)
- [By Will Ashworth] On September 3 Jarden (NYSE:JAH) announced it was acquiring Yankee Candle Company for $1.75 billion. Almost all the media I've seen since regarding the acquisition has been quite favorable. As I write this almost a full week has passed; the 10% uptick on the news is holding steady. It appears no one has a problem with this deal--except me. Read on and I'll explain why Jarden may be burning the candle at both ends.
The Deal's Positives
The company does a good job explaining why it's acquiring Yankee Candle. It comes down to six reasons:
1. Yankee Candle are market leaders in premium scented candles.
2. Its brand awareness results in repeat purchases providing recurring revenue.
3. It does well in good and bad economic cycles.
4. Free cash flow is strong and growing.
5. It will add 10% to its pro forma adjusted earnings per share and that's before any synergies.
6. It didn't have to go through a bidding war.
You don't have to be a rocket scientist to see that the deal boosts its margins in impressive fashion. Its adjusted gross margin will increase 320 basis points to 32.1% while its adjusted EBITDA margin improves 140 basis points to 13.2%. And all it has to do to achieve these improvements is to shell out $1.75 billion paid using cash on its books, new equity and some additional debt. In this low-rate environment it doesn't seem like a bad proposition. Especially if it can generate permanent cost savings through economies of scale, etc.
What it really brings to the table is top-line growth. In 2012, Yankee Candle's revenues increased by 7.4% year-over-year to $844.2 million. Meanwhile, Jarden's revenues in 2012 were flat year-over-year at $6.7 billion. Its 542 retail stores delivered same-store sales growth of 2.5% in 2012, which is more than respectable. Where it really shined was online, which saw comparable sales in its consumer direct - [By Will Ashworth]
One of the only ways to fight this is by getting bigger. A good example in another industry is Jarden (JAH), a consumer goods business with annual revenues of $7.4 billion. It�� as big as it is in order to be able to provide a larger assortment of products to Walmart (WMT), its biggest customer, representing 20% of overall sales. Without this wide assortment, Bentonville would have to go elsewhere for sales. The same scenario applies to cable and television content.
- [By John Udovich]
Everyone is familiar with�the Tupperware brand from�consumer products stock Tupperware Brands Corporation (NYSE: TUP) and you are probably familiar with the brands�of mid cap stock Jarden Corp (NYSE: JAH) along with small cap stocks Libbey Inc (NYSEMKT: LBY) and Lifetime Brands Inc (NASDAQ: LCUT); but what about the stocks themselves? Chances are, their brands or products are right under your nose at home and you probably don�� know anything about the mid cap or small cap stock behind them.
Hot High Tech Companies To Invest In 2014: Volterra Semiconductor Corporation(VLTR)
Volterra Semiconductor Corporation engages in the design, development, and marketing of analog and mixed-signal power management semiconductors for computing, storage, networking, and consumer markets. The company?s products include integrated voltage regulator semiconductors, integrated power protection and distribution semiconductors, and scalable voltage regulator semiconductor chipsets that transform, regulate, deliver, and monitor the power consumed by digital semiconductors. Its analog and mixed signal power management semiconductor products are primarily used in applications that require voltage regulating performance, such as data networking equipment, desktop and notebook computers, digital televisions, digital video recorders, game consoles, enterprise storage equipment, graphics cards, hard disk drives, printers, raid cards, servers, telecommunications equipment, base stations, and workstations. The company sells its products primarily to original equipment man ufacturers, original design manufacturers, contract equipment manufacturers, and merchant power supply manufacturers directly through its internal sales force, as well as indirectly through distributors and outsourced suppliers. It has operations in the United States, China, Singapore, Japan, Taiwan, and Germany. Volterra Semiconductor Corporation was founded in 1996 and is based in Fremont, California.
Advisors' Opinion:- [By Sally Jones]
Volterra Semiconductor Corp. (VLTR)
Up 30% over 12 months, Volterra Semiconductor Corp. has a market cap of $575.49 million; shares trade with a P/E of 41.20.
- [By Holly LaFon]
Volterra Semiconductor Corp. (1.2%) (VLTR - $23.00 - NASDAQ)(VLTR) is a California based designer of power management semiconductors for the computing, storage and networking sector. On August 15, 2013, the company received a $23.00 cash tender offer from nearby competitor Maxim Integrated Products Inc., a producer of integrated circuits for various industrial applications with greater scale and presence in the industry. The tender, which commenced on August 30, is expected to close on October 1 of this year. October 4, 2013.
Hot High Tech Companies To Invest In 2014: PDL BioPharma Inc.(PDLI)
PDL BioPharma, Inc. engages in intellectual property asset management and royalty bearing assets investment activities. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. It offers Queen et al. patents that cover humanized antibodies, methods for humanizing antibodies, polynucleotide encoding in humanized antibodies, and methods of producing humanized antibodies. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.
Advisors' Opinion:- [By Eric Volkman]
PDL BioPharma (NASDAQ: PDLI ) is expecting a healthy bump in its royalty revenue for the current quarter, which ends on June 30. The company has issued guidance for the period, estimating that it will take in royalty revenue of around $143 million. That would represent a 13% increase over the Q2 2012 figure of $126 million.
- [By John Reese]
Indeed, in 2013, the Greenblatt-based portfolio has bounced back strong, returning more than 50%. Below is a look at its current holdings.
EBIX, Inc. (EBIX)
Western Refining (WNR)
DirecTV (DTV)
ITT Educational Services (ESI)
Science Applications International (SAIC)
Weight Watchers International (WTW)
ConocoPhillips (COP)
AmSurg Corp. (AMSG)
PDL BioPharma (PDLI)
AFC Enterprises (AFCE)
Subscribe to Validea here��/p>
- [By Rebecca McClay]
Finally, PDL BioPharma Inc. (Nasdaq: PDLI) expects third-quarter revenue of about $97 million, as compared with actual revenue of $85 million for the third quarter last year, an approximate 14% increase. Analysts expect revenue of $97.9 million.
- [By John Udovich]
Small cap patent stocks Spherix Inc (NASDAQ: SPEX), PDL BioPharma Inc (NASDAQ: PDLI) and Endeavor IP Inc (OTCBB: ENIP) are among the�growing number of publicly traded�US entities focused on collecting and making money from various types of patents. After all, monetizing patents can lead to incredible returns. For example: Nomura analyst Rick Sherlund wrote in a research note back in November that Microsoft Corporation (NASDAQ: MSFT) is generating $2 billion per year in revenue from Android patent royalties and he�estimates that this revenue has a 95% margin. However, there are risks associated with investing in stocks that invest in patents because a bi-partisan bill called the Innovation Act (H.R. 3309) is�working its way through Congress to try and reign in the activities of so-called�"patent trolls" or rather companies that buy or license patents from others.
Hot High Tech Companies To Invest In 2014: Titan Pharmaceuticals Inc (TTNP)
Titan Pharmaceuticals, Inc., incorporated in February 1992, is a biopharmaceutical company developing therapeutics primarily for the treatment of central nervous system (CNS) disorders. The Company is focused primarily on clinical development of products that include Probuphine for the treatment of opioid addiction; Iloperidone: for the treatment of schizophrenia and related psychotic disorders, and Spheramine for the treatment of advanced Parkinson�� disease. Titan Pharmaceuticals is directly developing its product candidates and also utilizing corporate partnerships, including a collaboration with Bayer Schering Pharma AG, Germany (Bayer Schering) for the development of Spheramine to treat Parkinson�� disease, and Vanda Pharmaceuticals, Inc. (Vanda) for the development of iloperidone for the treatment of schizophrenia and related psychotic disorders.
Probuphine
Probuphine is the first product to utilize the Company�� ProNeura long-term drug delivery technology. Probuphine is designed to provide continuous, long-term therapeutic levels of the drug buprenorphine, an approved agent for the treatment of opioid addiction. In December 2007, the Company completed enrollment in a randomized, double-blind, placebo-controlled, multi-center Phase III clinical study of Probuphine in the treatment of opioid addiction. This 150 patient study, which is being conducted in the United States, will evaluate the safety and effectiveness of treatment with Probuphine versus placebo in reducing opioid addiction over 24 weeks of treatment. This study is part of a registration directed program intended to obtain marketing approval of Probuphine for the treatment of opioid addiction in Europe and the United States.
Iloperidone
Iloperidone was evaluated in a Phase III program comprising over 3,500 patients at more than 200 sites in 24 countries, administered and funded by Novartis Pharma AG (Novartis). In three completed efficacy studies conducted by Novartis, ilop! eridone statistically reduced the symptoms of schizophrenia compared to placebo. Iloperidone has also been investigated in three 12-month safety studies, which confirm safety and tolerability. A dose dependent increase in the Q-T Corrected (QTc) interval was observed and investigated further in a clinical study, and no clinically significant adverse events were observed. In September 2007, Vanda submitted a new drug application (NDA) with the United States Food and Drug Administration (FDA) for iloperidone. The NDA for iloperidone was officially accepted for review by the FDA in November 2007.
Spheramine
Spheramine is a cell-based therapeutic that utilizes the Company�� cell-coated microcarrier (CCM) technology, which enables the development of cell-based therapies for minimally invasive, site-specific delivery to the central nervous system of therapeutic factors precisely where they are needed. Spheramine consists of microcarriers coated with human retinal pigment epithelial cells that are intended to enhance brain levels of dopamine, a neurotransmitter deficient in certain brain regions in Parkinson�� disease, leading to movement disorders. Preclinical studies have demonstrated the preliminary efficacy and safety of Spheramine, including blinded studies in a primate model of Parkinson�� disease. In June 2007, enrollment was completed in a current multi-center, randomized, double-blind, placebo-controlled clinical trial of Spheramine in Parkinson�� disease. This Phase IIb clinical study enrolled 71 patients with advanced Parkinson�� disease (Hoehn and Yahr Stages III and IV) to further evaluate the efficacy, safety, and tolerability of Spheramine.
Bayer Schering, the Company�� corporate partner for worldwide development and commercialization of Spheramine, is funding the clinical development program for Spheramine. Under an agreement, Bayer Schering has received exclusive, worldwide development, manufacturing and commercialization rights, and, in ad! dition to! the clinical and manufacturing development funding and milestone payments, Bayer Schering will pay Titan Pharmaceuticals a royalty on future product sales.
Advisors' Opinion:- [By CRWE]
Today, TTNP surged (+2.76%) up +0.018 at $.689 with 152,996 shares in play thus far (ref. google finance Delayed: 2:02PM EDT October 1, 2013).
Titan Pharmaceuticals, Inc. previously reported that the U.S. Food and Drug Administration (FDA) has granted the request for a meeting to discuss Probuphine庐. The meeting is scheduled for November 19, 2013. The FDA has designated this as a Type C meeting and has requested the submission of briefing materials by October 7, 2013.
Hot High Tech Companies To Invest In 2014: John Wiley & Sons Inc (JW.A)
John Wiley & Sons, Inc., incorporated on January 15, 1904, is a global provider of knowledge and knowledge-based services in areas of research, professional development and education. Core businesses produce scientific, technical, medical and scholarly research journals, reference works, books, database services, and advertising; professional books and certification, assessment and training services, and education content and services, including online program management for colleges and universities and integrated online teaching and learning resources for instructors and students. The Company sells its products to customers in the Middle East (including Iran and Syria), Africa (including Sudan), Cuba, and other developing markets where it does not have operating subsidiaries.
Research
The Company�� Research business serves the world�� research and scholarly communities and is a publisher for professional and scholarly societies. Research�� mission is to support researchers, professionals and learners in the discovery and use of research knowledge to achieve results that help shape the future. Research products include scientific, technical, medical and scholarly research journals, books, major reference works, databases, clinical decision support tools and laboratory manuals and workflow tools, in the publishing areas of the physical sciences and engineering, health sciences, social science and humanities and life sciences. Research customers include academic, corporate, government, and public libraries; researchers; scientists; clinicians; engineers and technologists; scholarly and professional societies, and students and professors. The Company�� Research products are sold and distributed globally, online and in print through multiple channels, including research libraries and library consortia, independent subscription agents, direct sales to professional society members, bookstores, online booksellers and other customers. Publishing centers include Australia, Ge! rmany, India, Singapore, the United Kingdom and the United States. Research accounted for approximately 57% of total Company revenue (fiscal 2013). The Company�� Research business is a provider of content and services in evidence-based medicine (EBM). Through the Company�� alliance with The Cochrane Collaboration, the Company publishes The Cochrane Library.
Wiley Online Library, the online publishing platform for the Company�� Research business, is a multidisciplinary collections of online resources covering life, health and physical sciences, social science and the humanities. Wiley Online Library delivers seamless integrated access to over four million articles from 1,500 journals, 13,000 online books, and hundreds of reference works, laboratory protocols and databases. Wiley Online Library provides the user with intuitive navigation, enhanced discoverability, expanded functionality and a range of personalization options. Wiley Open Access is the Company�� publishing program for open-access research articles. Under the Wiley Open Access business model, research articles submitted by authors are published and compiled by subject area into open-access journals. In addition to Wiley Open Access, the Company provides authors with the opportunity to make their individual research articles that were published within the Company�� paid subscription journals freely available to the general public through OnlineOpen.
Professional Development (PD)
The Company�� Professional Development business acquires, develops and publishes professional books, subscription products, certification and training services and online applications in the areas of business, finance, accounting, workplace learning, management, leadership, technology, behavioral health, engineering/ architecture and education. Products are developed in print and digitally for worldwide distribution through multiple channels, including major chains and online booksellers, independent bookstores, libr! aries, co! lleges and universities, warehouse clubs, corporations, direct to consumer, websites and other online applications. Publishing centers include Australia, Canada, Germany, India, Singapore, the United Kingdom and the United States. Professional Development accounted for approximately 24% of total Company revenue in fiscal year 2013. Professional Development revenue by product type includes eBooks and Print Books; Online Training and Assessment which is revenue from the sale of products and services focusing on workplace effectiveness and career success; Publishing Rights which is revenue from the licensing of the right to republish Wiley content either online or in print; Journal Subscriptions online and in print to professionals, and Other.
Education
The Company�� Education business produces educational content and services, including online program management for colleges and universities and integrated online teaching and learning resources for instructors and students. Education�� mission is to help teachers teach and students learn by delivering to students, faculty and institutions throughout the world personalized content, tools and services that demonstrate results. Education offers products and services principally delivered through college bookstores and online distributors, with customers having access to content in multi-media formats, as well as the traditional textbook. Education�� solutions are available in each of its publishing disciplines, including the sciences, engineering, computer science, mathematics, business and accounting, statistics, geography, hospitality and the culinary arts, education, psychology and modern languages. Education accounted for approximately 19% of total Company revenue in fiscal year 2013. Education revenue by product type includes eBooks and Print Textbooks; Online Program Management; WileyPLUS, the Company�� online learning solution; revenue from the licensing of publishing content rights and Other Nontraditional and Digita! l Product! s, such as custom publishing and other content adaption��.
Education offers online learning solutions including WileyPLUS, it�� research-based, online environment for effective course teaching and learning that is integrated with a complete digital textbook. WileyPLUS improves student learning through instant feedback, personalized learning plans, and self- evaluation tools and a range of course-oriented activities, including online planning, presentations, study, homework and testing. The Company also provides the services of the Wiley Faculty Network, a global community of faculty that offers guidance, training, and resources. Through the Wiley Faculty Network, instructors and administrators can collaborate with each other, attend virtual and live events, and utilize a wealth of resources all designed to help them grow as educators.
Journal Products
The Company publishes approximately 1,600 Research and Professional Development journals. Journal subscription revenue and other related publishing income, such as advertising, backfile sales, the licensing of publishing rights, journal reprints and individual article sales accounted for approximately 48% of the Company�� consolidated fiscal year 2013 revenue. The journal portfolio includes titles owned by the Company, in which case they may or may not be sponsored by a professional society; titles owned jointly with a professional society; and titles owned by professional societies and published by the Company pursuant to long-term contracts. The Company also enters into agreements with outside independent editors of journals that state the duties of the editors, and the fees and expenses for their services. The Company sells journal subscriptions directly through Company sales representatives; indirectly through independent subscription agents; through promotional campaigns, and through memberships in professional societies for those journals that are sponsored by societies. Journal subscriptions are primarily! licensed! through contracts for online content delivered through the Company�� online platform, Wiley Online Library.
Book Products
The Company�� Book products and book related publishing revenue, such as advertising and the sale of publishing rights, accounted for approximately 48% of the Company�� fiscal year 2013 revenue. The Company enters into agreements with authors that state the terms and conditions under which the materials will be published, the name in which the copyright will be registered, the basis for any royalties, and other matters. The Company develops content in a digital format that can be used for online and print products, resulting in productivity and efficiency savings, and enabling print-on-demand delivery. Book content is available online through Wiley Online Library, WileyPLUS, Custom Select and other platforms. Ebooks are delivered to intermediaries, including Amazon, Apple and Google for re-sale to individuals in various industry-standard formats, which are now also the preferred deliverable for licensees of all types, including foreign language publishers.
Other Digital Products and Services
The Company is focused on delivering content-enabled services which improve learning, career management and effectiveness for its target communities. The Inscape and ELS businesses, along with the Company�� Pfeiffer brand, represent the Company�� professional training and assessment services. These businesses offer a variety of classroom learning solutions and e-learning activities that are delivered to customers directly through online digital delivery platforms and also through an authorized distributor network of independent consultants, trainers and coaches. The Company�� professional training and assessment services offer highly flexible packages and modules for its customers that include online pre-work and profile assessments, self-study materials, online videos, mobile apps and other sophisticated planning tools.
The Com! pany generates advertising revenue from print and online journal subscription products; its online publishing platform, Wiley Online Library; the Wiley Job Network, a full service online job board; online events such as webinars and virtual conferences; community interest websites such as spectroscopyNOW.com and websites for the Company�� brands like Dummies.com. The Company�� publications and services are sold throughout most of the world through operations located in Europe, Canada, Australia, Asia, and the United States. Advisors' Opinion:- [By Geoff Gannon]
Here, you want to compare the return on the company's buyback with the return you could achieve. However, you want to keep in mind that while you would pay a tax on the dividend the company does not pay a tax on the buyback. Let's say I imagine John Wiley (JW.A) will get a 10% return on its buyback. Likewise, I think I can go out and return 10% a year myself picking my own stocks. In this case, which should I prefer? Should I prefer John Wiley paid a dividend or used all of its free cash flow to buyback stock?
- [By Arie Goren]
After running this screen on May 21, 2013, before the markets' open, I discovered the following eight stocks: Sunoco Logistics Partners LP (SXL), Leggett & Platt Inc (LEG), Copa Holdings SA (CPA), RPC Inc. (RES), Tupperware Brands Corp. (TUP), Herbalife Ltd. (HLF), John Wiley & Sons Inc. (JW.A) and C.H. Robinson Worldwide Inc. (CHRW).
Hot High Tech Companies To Invest In 2014: Akzo Nobel NV (AKZA)
Akzo Nobel NV is a manufacturer of paints, coatings and specialty chemicals based in the Netherlands. The Company operates within four segments. Within Buildings and Infrastructure segment, it manufactures decorative paints, protective, powder and coil coatings, and wood finishes for construction industry. Transportation segment offers specialty and powder coatings for automotive parts, peroxides, metal alkyls, and automotive, marine, yacht and aerospace coatings. Consumer Goods segment supplies finishes, adhesives and powder coatings for wood, specialty finishes for electronics, packaging coatings, surfactants, polymers and amines used in manufacture of soap, personal products and detergents. Within Industrial segment, it produces bulk chemicals, specialty chemicals, pulp and paper. In October 2013, it divested its Building Adhesives business; and acquired 50% stake and management control of Sadolin Paints Oman SAOC through joint venture agreement with Omar Zawawi Establishment LLC. Advisors' Opinion:- [By Jonathan Morgan]
Akzo Nobel NV (AKZA) tumbled 8 percent to 43.52 euros, the biggest slide since 2008. Europe�� largest paintmaker reported a 14 percent decline in second-quarter earnings before interest, taxes, depreciation and amortization to 474 million euros. Sales fell 4 percent to 3.87 billion euros. Analysts had predicted 3.9 billion euros in revenue on average, based on estimates collated by Bloomberg.
No comments:
Post a Comment